REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in glioma

BACKGROUND/AIM: Repressor element silencing transcription factor (REST) is a transcription repressor, expressed in several malignancies. This study aims to evaluate the prognostic values of REST and its splicing variant REST4 in glioma, and investigate the potential correlation between REST and REST...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Cuilin, Zou, Hecun, Wang, Zhifei, Tang, Xinyue, Fan, Xitang, Zhang, Ke, Liu, Jianqiu, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968789/
https://www.ncbi.nlm.nih.gov/pubmed/29861627
http://dx.doi.org/10.2147/DDDT.S161602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968789/
https://www.ncbi.nlm.nih.gov/pubmed/29861627
http://dx.doi.org/10.2147/DDDT.S161602

Ejemplares similares